Triad biopharmaceutical company seeks to raise $6 million

John Joyce
Triad biopharmaceutical company seeks to raise $6 million

A rollercoaster year in 2018 saw the company's stock fall dramatically, but successful testing of potential drugs late in the year helped the stock price recover handily heading into a so far more stable 2019.